References
- LipskyPERheumatoid arthritisFauciALangfordCHarrison’s RheumatologyNew YorkMcGraw-Hill20103342
- LeeDMWeinblattMERheumatoid arthritisLancet2001358928590391111567728
- European Musculoskeletal Conditions Surveillance and Information NetworkMusculoskeletal Health in Europe: Report v5.02012 Available from: http://www.eumusc.net/myUploadData/files/Musculoskeletal%20Health%20in%20Europe%20Report%20v5.pdfAccessed November 19, 2015
- SilmanAJHochbergMCDescriptive epidemiology of rheumatoid arthritisHochbergMCSilmanAJSmolenJSWeinblattMEWeismanMHRheumatoid ArthritisAmsterdamElsevier20091522
- SanghaOEpidemiology of rheumatic diseasesRheumatology (Oxford)200039Suppl 2312
- Deutsche Rheuma-ForschungszentrumDaten der Kerndokumentation 2013 Available from: http://dgrh.de/fileadmin/media/Forschung/Versorgungsforschung/ErwachsenenKerndok/Standardpraesentation_2013_extern.pdfAccessed November 19, 2015
- SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201373349250924161836
- SinghJASaagKGBridgesSLJr2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritisArthritis Rheumatol201668112626545940
- SinghJAChristensenRWellsGABiologics for rheumatoid arthritis: an overview of Cochrane reviewsSao Paulo Med J20131285309310
- YaziciYAbatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto … let’s call the whole thing offArthritis Res Ther201214110422353683
- CascianoRMalangoneERamachandranAGagliardinoJJA quantitative assessment of patient barriers to insulinInt J Clin Pract201165440841421401829
- FallowfieldLAtkinsLCattSPatients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancerAnn Oncol200617220521016239231
- MohrDCBoudewynACLikoskyWLevineEGoodkinDEInjectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectAnn Behav Med200123212513211394554
- BarberNParsonsJCliffordSDarracottRHorneRPatients’ problems with new medication for chronic conditionsQual Saf Health Care200433172175
- GlombiewskiJANestoriucYRiefWGlaesmerHBraehlerEMedication adherence in the general populationPLoS One2012712e5053723272064
- PasmaAvan’t SpijkerAHazesJMBusschbachJJLuimeJJFactors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic reviewSemin Arthritis Rheum2013431182823352247
- van den BemtBJZwikkerHEvan den EndeCHMedication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literatureExpert Rev Clin Immunol20128433735122607180
- BartonJLPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapyPatient Prefer Adherence2009333534420016797
- ChiltonFCollettRATreatment choices, preferences and decision-making by patients with rheumatoid arthritisMusculoskeletal Care20086111417726671
- FraenkelLBogardusSConcatoJFelsonDUnwillingness of rheumatoid arthritis patients to risk adverse effectsRheumatology (Oxford)200241325326111934960
- Goekoop-RuitermanYPde Vries-BouwstraJKAllaartCFPatient preferences for treatment: report from a randomized comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)Ann Rheum Dis20076691227123217405834
- LemppHHofmannDHatchSLScottDLPatients’ views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative studyBMC Musculoskelet Disord20121320023078166
- ScarpatoSAntivalleMFavalliEGPatient preferences in the choice of anti-TNF therapies in rheumatoid arthritis: results from a questionnaire survey (RIVIERA study)Rheumatology (Oxford)201049228929419920093
- WillekePBeckerHWassenbergSPavenstädtHJacobiAMBewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen [Patient/rheumatologist evaluation of infusion treatment for rheumatoid arthritis]Z Rheumatol2011703232234236238 German21359555
- FlynnTNLouviereJJPetersTJCoastJBest-worst scaling: what it can do for health care research and how to do itJ Health Econ200726117118916707175
- PotoglouDBurgePFlynnTBest-worst scaling vs. discrete choice experiments: an empirical comparison using social care dataSoc Sci Med201172101717172721530040
- MarleyAALouviereJJSome probabilistic models of best, worst, and best-worst choicesJ Math Psychol200549464480
- Deutsche Gesellschaft für RheumatologieBerlin: Rheuma in Zahlen: Betroffene Menschen in Deutschland2008 Available from: http://dgrh.de/fileadmin/media/Die_DGRH/Presse/Rheuma_in_Zahlen_presse_aktual.pdfAccessed November 19, 2015
- FederovVTheory of Optimal ExperimentsNew YorkAcademic Press1972
- JohnsonFRLancsarEMarshallDConstructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceValue Health201316131323337210
- LeebBFHaindlPMMaktariANothnaglTRintelenBPatient-centered rheumatoid arthritis disease activity assessment by a modified RADAIJ Rheumatol20083571294129918484698
- RintelenBHaindlPMSautnerJLeebBADeutschCLeebBFThe rheumatoid arthritis disease activity index-5 in daily use: proposal for disease activity categoriesJ Rheumatol200936591892419332635
- HorneRWeinmanJHankinsMThe Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing cognitive representations of medicationPsychol Health1999141124
- HorneRWeinmanJPatients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnessJ Psychosom Res199947655556710661603
- NeameRHammondABeliefs about medications: a questionnaire survey of people with rheumatoid arthritisRheumatology (Oxford)200544676276715741193
- AndersonJCaplanLYazdanyJRheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practiceArthritis Care Res (Hoboken)201264564064722473918
- CliffordSBarberNHorneRUnderstanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns frameworkJ Psychosom Res2008641414618157998
- FinnALouviereJJDetermining the appropriate response to evidence of public concern: the case of food safetyJ Public Policy Mark19921121225
- AugerPDeevinneyTMLouviereJUsing best-worst scaling methodology to investigate ethical beliefs across countriesJ Bus Ethics200770299326
- FlynnTNLouviereJJPetersTJCoastJEstimating preferences for a dermatology consultation using best-worst scaling: comparison of various methods of analysisBMC Med Res Methodol200887619017376
- Gesundheitsberichterstattung des BundesDas Informations system der Gesundheitsberichterstattung des Bundes2014 Available from: http://www.gbe-bund.deAccessed November 19, 2015
- SkjoldborgUSLauridsenJJunkerPReliability of the discrete choice experiment at the input and output level in patients with rheumatoid arthritisValue Health200912115315819911446
- AugustovskiFBeratarrecheaAIrazolaVPatient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experimentValue Health201316238539323538191
- PoulosCHauberABGonzálezJMTurpcuAPatients’ willingness to trade off between the duration and frequency of rheumatoid arthritis treatmentsArthritis Care Res (Hoboken)20146671008101524339373
- LouderAMSinghASavernoKPatient preferences regarding rheumatoid arthritis therapies: a conjoint analysisAm Health Drug Benefits2016928493